MedicarePartD.guide

A non-government resource built from CMS public data

mResvia on SilverScript Choice (S5601-014)

RSV vaccine

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 0.5 per 999 days.

$2.16
Patient pays / month, after deductible
$12.02
Patient pays / month, before the $615.00 deductible
$6.49
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MRESVIA 50 ug/.5mL Suspension at a preferred retail pharmacy, from the plan's negotiated price of $12.02 for a month.

Prior authRequired on the covered form· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)

Other Part D vaccines on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-014